XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Shareholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   22,014    
Beginning balance at Dec. 31, 2022 $ (438,177) $ 220 $ 5,182 $ (443,579)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income 11,465     11,465
Exercise of common stock options (in shares)   17    
Exercise of common stock options 389   389  
Stock-based compensation (in shares)   271    
Stock-based compensation 4,639 $ 3 4,636  
Repurchases of common stock (in shares)   (118)    
Repurchases of common stock (3,363) $ (1) (3,362)  
Ending balance (in shares) at Apr. 01, 2023   22,184    
Ending balance at Apr. 01, 2023 (425,047) $ 222 6,845 (432,114)
Beginning balance (in shares) at Dec. 31, 2022   22,014    
Beginning balance at Dec. 31, 2022 (438,177) $ 220 5,182 (443,579)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income 12,219      
Ending balance (in shares) at Jul. 01, 2023   22,214    
Ending balance at Jul. 01, 2023 (419,141) $ 222 11,997 (431,360)
Beginning balance (in shares) at Apr. 01, 2023   22,184    
Beginning balance at Apr. 01, 2023 (425,047) $ 222 6,845 (432,114)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income 754     754
Exercise of common stock options (in shares)   3    
Exercise of common stock options 39   39  
Stock-based compensation (in shares)   33    
Stock-based compensation 5,251 $ 0 5,251  
Repurchases of common stock (in shares)   (6)    
Repurchases of common stock (138) $ 0 (138) 0
Ending balance (in shares) at Jul. 01, 2023   22,214    
Ending balance at Jul. 01, 2023 $ (419,141) $ 222 11,997 (431,360)
Beginning balance (in shares) at Dec. 30, 2023 22,235 22,235    
Beginning balance at Dec. 30, 2023 $ (441,928) $ 222 16,716 (458,866)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income (7,482)     (7,482)
Stock-based compensation (in shares)   134    
Stock-based compensation 4,117 $ 1 4,116  
Repurchases of common stock (in shares)   (43)    
Repurchases of common stock (570)   (570)  
Ending balance (in shares) at Mar. 30, 2024   22,326    
Ending balance at Mar. 30, 2024 $ (445,863) $ 223 20,262 (466,348)
Beginning balance (in shares) at Dec. 30, 2023 22,235 22,235    
Beginning balance at Dec. 30, 2023 $ (441,928) $ 222 16,716 (458,866)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income $ (12,533)      
Ending balance (in shares) at Jun. 29, 2024 22,355 22,355    
Ending balance at Jun. 29, 2024 $ (446,964) $ 224 24,211 (471,399)
Beginning balance (in shares) at Mar. 30, 2024   22,326    
Beginning balance at Mar. 30, 2024 (445,863) $ 223 20,262 (466,348)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income (5,051)     (5,051)
Stock-based compensation (in shares)   32    
Stock-based compensation 3,992 $ 1 3,991  
Repurchases of common stock (in shares)   (3)    
Repurchases of common stock $ (42)   (42)  
Ending balance (in shares) at Jun. 29, 2024 22,355 22,355    
Ending balance at Jun. 29, 2024 $ (446,964) $ 224 $ 24,211 $ (471,399)